Clostridium butyricum potentially improves inflammation and immunity through alteration of the microbiota and metabolism of gastric cancer patients after gastrectomy

BackgroundGastrectomy is the most effective treatment to improve the clinical survival rate of patients with gastric cancer. However, the pathophysiological changes caused by gastrectomy have seriously affected the postoperative recovery.MethodsIn the present trial, Ataining (containing C. butyricum...

Full description

Bibliographic Details

Published in:	Frontiers in Immunology
Main Authors:	Wenjie Cao, Cihua Zheng, Xuan Xu, Rui Jin, Feng Huang, Meng Shi, Zhipeng He, Yufeng Luo, Lulin Liu, Zhaoxia Liu, Jing Wei, Xiaorong Deng, Tingtao Chen
Format:	Article
Language:	English
Published:	Frontiers Media S.A. 2022-11-01
Subjects:	Gastric cancer Clostridium butyricum SCFAs gut microbiota gastrectomy
Online Access:	https://www.frontiersin.org/articles/10.3389/fimmu.2022.1076245/full